RNA protein interaction in neurons

Annual Review of Neuroscience

Volumn 36, Issue , 2013, Pages 243-270

  Darnell, Robert B ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Elavl; FMRP; HITS CLIP; MicroRNA; Neuron specific splicing factors; Nova

Indexed keywords

ARGONAUTE PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCITONIN GENE RELATED PEPTIDE; CRE RECOMBINASE; HU ANTIGEN; MESSENGER RNA; MICRORNA; PROTEIN ELAV2; PROTEIN ELAV3; PROTEIN ELAV4; PROTEIN FMRP; PROTEIN NOVA1; PROTEIN NOVA2; PROTEIN NSR100; PROTEIN PTBP2; PROTEIN RBFOX3; REELIN; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AUTISM; CHROMOSOME PAIRING; CYTOLOGY; FRAGILE X SYNDROME; HIGH THROUGHPUT SEQUENCING; HYDROGEN BOND; MAMMALIAN GENETICS; MYOTONIC DYSTROPHY; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN RNA BINDING; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; STOICHIOMETRY; ULTRAVIOLET IRRADIATION;

ANIMALS; BRAIN; NEURONS; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84880312659     PISSN: 0147006X     EISSN: 15454126     Source Type: Book Series    
DOI: 10.1146/annurev-neuro-062912-114322     Document Type: Review

References (214)

1. Aakalu G, Smith WB, Nguyen N, Jiang C, Schuman EM. 2001. Dynamic visualization of local protein synthesis in hippocampal neurons. Neuron 30:489-5022
2. Akamatsu W, Fujihara H, Mitsuhashi T, Yano M, Shibata S, et al. 2005. The RNA-binding protein HuD regulates neuronal cell identity and maturation. Proc. Natl. Acad. Sci. USA 102:4625-300
3. Akamatsu W, Okano HJ, Osumi N, Inoue T, Nakamura S, et al. 1999. Mammalian ELAV-like neuronal RNAbinding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc. Natl. Acad. Sci. USA 96:9885-900
4. Alarcon JM, Hodgman R, Theis M, Huang YS, Kandel ER, Richter JD. 2004. Selective modulation of some forms of schaffer collateral-CA1 synaptic plasticity in mice with a disruption of the CPEB-1 gene. Learn. Mem. 11:318-277
5. Amara SG, Jonas V, Rosenfeld MG, Ong ES, Evans R. 1982. Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products. Nature 298:240-444
6. Antic D, Lu N, Keene JD. 1999. ELAV tumor antigen, Hel-N1, increases translation of neurofilament M mRNA and induces formation of neurites in human teratocarcinoma cells. Genes Dev. 13:449-611
7. Ashley CTJ, Wilkinson KD, Reines D, Warren ST. 1993. FMR1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-666
8. Bakker CE, Verheij C, Willemsen R, van derHelm R, Oerlemans F, et al. 1994. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell 78:23-333
9. Barreau C, Paillard L, Müreau, Osborne HB. 2006. Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie 88:515-255
10. Battle DJ, Kasim M, Yong J, Lotti F, Lau CK, et al. 2006. The SMNcomplex: an assembly machine for RNPs. Cold Spring Harb. Symp. Quant. Biol. 71:313-200
11. Bear MF, Huber KM, Warren ST. 2004. The mGluR theory of fragile X mental retardation. Trends Neurosci. 27:370-777
12. Behrends U, Schneider I, Rossler S, Frauenknecht H, Golbeck A, et al. 2003. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int. J. Cancer 106:244-511
13. Bhakar AL, Dolen G, Bear MF. 2012. The pathophysiology of fragileX(and what it teaches us about synapses). Annu. Rev. Neurosci. 35:417-433
14. Bier E, Ackerman L, Barbel S, Jan L, Jan YN. 1988. Identification and characterization of a neuron-specific nuclear antigen in Drosophila. Science 240:913-166
15. Blanchette M, Green RE, Brenner SE, Rio DC. 2005. Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila. Genes Dev. 19:1306-144
16. Blencowe BJ, Ahmad S, Lee LJ. 2009. Current-generation high-throughput sequencing: deepening insights into mammalian transcriptomes. Genes Dev. 23:1379-866
17. Bolognani F, Perrone-Bizzozero NI. 2008. RNA-protein interactions and control of mRNA stability in neurons. J. Neurosci. Res. 86:481-899
18. Boutz PL, Stoilov P, Li Q, Lin CH, Chawla G, et al. 2007. A post-transcriptional regulatory switch in polypyrimidine tract-binding proteins reprograms alternative splicing in developing neurons. Genes Dev. 21:1636-522
19. Buckanovich RJ, Darnell RB. 1997. The neuronal RNA binding protein Nova-1 recognizes specific RNA targets in vitro and in vivo. Mol. Cell. Biol. 17:3194-2011
20. Buckanovich RJ, Posner JB, Darnell RB. 1993. Nova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor system. Neuron 11:657-722
21. Buckanovich RJ, Yang YY, Darnell RB. 1996. The onconeural antigen Nova-1 is a neuron-specific RNAbinding protein, the activity of which is inhibited by paraneoplastic antibodies. J. Neurosci. 16:1114-222
22. Burd CG, Dreyfuss G. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265:615-211
23. Burns DM, D'AmbrogioA, Nottrott S, Richter JD. 2011. CPEBand two poly(A) polymerases controlmiR-122 stability and p53 mRNA translation. Nature 473:105-88
24. Calarco JA, Superina S, O'Hanlon D, Gabut M, Raj B, et al. 2009. Regulation of vertebrate nervous system alternative splicing and development by an SR-related protein. Cell 138:898-9100
25. Calarco JA, Zhen M, Blencowe BJ. 2011. Networking in a global world: establishing functional connections between neural splicing regulators and their target transcripts. RNA 17:775-911
26. Campos AR, Rosen DR, Robinow SN, White K. 1987. Molecular analysis of the locus elav in Drosophila melanogaster: a gene whose embryonic expression is neural specific. EMBO J. 6:425-311
27. Castle JC, Zhang C, Shah JK, Kulkarni AV, Kalsotra A, et al. 2008. Expression of 24, 426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines. Nat. Genet. 40:1416-255
28. Chan RC, Black DL. 1997. The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol. 17:4667-766
29. Charizanis K, Lee KY, Batra R, Goodwin M, Zhang C, et al. 2012. Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron 75:437-500
30. Chen CY, Shyu AB. 2011. Mechanisms of deadenylation-dependent decay. Wiley Interdiscip. Rev. RNA 2:167-833
31. Chen M, Manley JL. 2009. Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches. Nat. Rev. Mol. Cell Biol. 10:741-544
32. Chi SW, Zang JB, Mele A, Darnell RB. 2009. Argonaute HITS-CLIP decodesmicroRNA-mRNA interaction maps. Nature 460:479-866
33. Christie SB, Akins MR, Schwob JE, Fallon Jr. 2009. The FXG: a presynaptic fragile X granule expressed in a subset of developing brain circuits. J. Neurosci. 29:1514-244
34. Cooper TA, Wan L, Dreyfuss G. 2009. RNA and disease. Cell 136:777-933
35. Corrionero A, Valcarcel J. 2009. RNA processing: redrawing themap of charted territory. Mol. Cell 36:918-199
36. Da Cruz S, Cleveland DW. 2011. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr. Opin. Neurobiol. 21:904-199
37. Darnell JC, Fraser CE, Mostovetsky O, Stefani G, Jones TA, et al. 2005. Kissing complex RNAs mediate interaction between the Fragile-X mental retardation protein KH2 domain and brain polyribosomes. Genes Dev. 19:903-188
38. Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB. 2001. Fragile X mental retardation protein targets G Quartet mRNAs important for neuronal function. Cell 107:489-999
39. Darnell JC, Van Driesche SJ, Zhang C, Hung KY, Mele A, et al. 2011. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146:247-611
40. Darnell RB. 1996. Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain. Proc. Natl. Acad. Sci. USA 93:4529-366
41. Darnell RB. 2006. Developing global insight into RNA regulation. Cold Spring Harb. Symp. Quant. Biol. 71:321-277
42. Darnell RB. 2010. HITS-CLIP: panoramic views of protein-RNA regulation in living cells. Wiley Interdiscip. Rev. RNA 1:266-866
43. Darnell RB, DeAngelis LM. 1993. Regression of small-cell lung carcinoma in patients with paraneoplastic neuronal antibodies. Lancet 341:21-222
44. Darnell RB, Furneaux H, Posner JB. 1989. Characterization of antigens bound by CSF and serum of a patient with cerebellar degeneration: co-expression in Purkinje cells and tumor lines of neuroectodermal origin. Neurology 39:3855
45. Darnell RB, Posner JB. 2003a. Observing the invisible: successful tumor immunity in humans. Nat. Immunol. 4:2011
46. Darnell RB, Posner JB. 2003b. Paraneoplastic syndromes involving the nervous system. N. Engl. J. Med. 349:1543-544
47. Darnell RB, Posner JB. 2011. Paraneoplastic Syndromes (Contemporary Neurology Series). New York: Oxford Univ. Presss
48. Dean JL, Wait R, Mahtani KR, Sully G, Clark AR, Saklatvala J. 2001. The 3′ untranslated region of tumor necrosis factor alpha mRNA is a target of the mRNA-stabilizing factor HuR. Mol. Cell. Biol. 21:721-300
49. Dhaenens CM, Tran H, Frandemiche ML, Carpentier C, Schraen-Maschke S, et al. 2011. Mis-splicing ofTau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing. Biochim. Biophys. Acta 1812:732-422
50. Donnelly CJ, Willis DE, Xu M, Tep C, Jiang C, et al. 2011. Limited availability of ZBP1 restricts axonal mRNA localization and nerve regeneration capacity. EMBO J. 30:4665-777
51. Dor Y, Brown J, Martinez OI, Melton DA. 2004. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-466
52. Doyle JP, Dougherty JD, Heiman M, Schmidt EF, Stevens TR, et al. 2008. Application of a translational profiling approach for the comparative analysis of CNS cell types. Cell 135:749-622
53. Dredge BK, Darnell RB. 2003. Nova regulates GABA(A) receptor gamma2 alternative splicing via a distal downstream UCAU-rich intronic splicing enhancer. Mol. Cell. Biol. 23:4687-7000
54. Dredge BK, Jensen KB. 2011. NeuN/Rbfox3 nuclear and cytoplasmic isoforms differentially regulate alternative splicing and nonsense-mediated decay of Rbfox2. PLoS ONE 6:e215855
55. Dredge BK, Stefani G, Engelhard CC, Darnell RB. 2005. Nova autoregulation reveals dual functions in neuronal splicing. EMBO J. 24:1608-200
56. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, et al. 2010. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol. 17:187-933
57. Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, et al. 2010. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 65:373-844
58. Ellington AD, Szostak JW. 1990. In vitro selection of RNA molecules that bind specific ligands. Nature 346:818-222
59. Eom T, Zhang C, Wang H, Lay K, Fak J, Noebels JL, Darnell RB. 2013. NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure. eLIFE 2:e001788
60. Fan XC, Myer VE, Steitz JA. 1997. AU-rich elements target small nuclear RNAs as well as mRNAs for rapid degradation. Genes Dev. 11:2557-688
61. Fan XC, Steitz JA. 1998. Overexpression of Hu R, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448-600
62. Fiore R, Siegel G, Schratt G. 2008. MicroRNA function in neuronal development, plasticity and disease. Biochim. Biophys. Acta 1779:471-788
63. Gao FB, Carson CC, Levine T, Keene JD. 1994. Selection of a subset of mRNAs from combinatorial 3′ untranslated region libraries using neuronal RNA-binding protein Hel-N1. Proc. Natl. Acad. Sci. USA 91:11207-111
64. Gehman LT, Stoilov P, Maguire J, Damianov A, Lin CH, et al. 2011. The splicing regulator Rbfox1 (A2BP1) controls neuronal excitation in the mammalian brain. Nat. Genet. 43:706-111
65. Green R, Ellington AD, Bartel DP, Szostak JW. 1991. In vitro genetic analysis: selection and amplification of rare functional nucleic acids. Methods Compan. Methods Enzymol. 2:75-866
66. Gu W, Pan F, Zhang H, Bassell GJ, Singer RH. 2002. A predominantly nuclear protein affecting cytoplasmic localization of beta-actin mRNA in fibroblasts and neurons. J. Cell Biol. 156:41-511
67. Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J, et al. 2010. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141:129-411
68. Hagan JP, Piskounova E, Gregory RI. 2009. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Nat. Struct. Mol. Biol. 16:1021-255
69. Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, et al. 2004. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol. Cell. Biol. 24:4448-644
70. He M, Liu Y, Wang X, Zhang MQ, Hannon GJ, Huang ZJ. 2012. Cell-type-based analysis of microRNA profiles in the mouse brain. Neuron 73:35-488
71. Heiman M, Schaefer A, Gong S, Peterson JD, Day M, et al. 2008. A translational profiling approach for the molecular characterization of CNS cell types. Cell 135:738-488
72. Heo I, Joo C, Kim YK, Ha M, Yoon MJ, et al. 2009. TUT4 in concert with Lin28 suppresses microRNA biogenesis through pre-microRNA uridylation. Cell 138:696-7088
73. Hinman MN, Lou H. 2008. Diverse molecular functions of Hu proteins. Cell Mol. Life Sci. 65:3168-811
74. Holt CE, Bullock SL. 2009. SubcellularmRNAlocalization in animal cells andwhy it matters. Science 326:1212-166
75. Homyk TJ, Szidonya J, Suzuki DT. 1980. Behavioral mutants of Drosophila melanogaster. III. Isolation and mapping of mutations by direct visual observations of behavioral phenotypes. Mol. Gen. Genet. 177:553-655
76. Hormigo A, Dalmau J, Rosenblum MK, River ME, Posner JB. 1994. Immunological and pathological study of anti-Ri-associated encephalopathy. Ann. Neurol. 36:896-9022
77. Huang CS, Shi SH, Ule J, Ruggiu M, Barker LA, et al. 2005. Commonmolecular pathways mediate long-term potentiation of synaptic excitation and slow synaptic inhibition. Cell 123:105-188
78. Huang YW, Ruiz CR, Eyler EC, Lin K, Meffert MK. 2012. Dual regulation of miRNA biogenesis generates target specificity in neurotrophin-induced protein synthesis. Cell 148:933-466
79. Huttelmaier S, Zenklusen D, Lederer M, Dictenberg J, Lorenz M, et al. 2005. Spatial regulation of beta-actin translation by Src-dependent phosphorylation of ZBP1. Nature 438:512-155
80. Imai T, Tokunaga A, Yoshida T, Hashimoto M, Mikoshiba K, et al. 2001. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell. Biol. 21:3888-9000
81. Ince-Dunn G, Okano HJ, Jensen KB, Park WY, Zhong R, et al. 2012. Neuronal Elav-like (Hu) proteins regulateRNAsplicing and abundance to control glutamate levels and neuronal excitability. Neuron 75:1067-800
82. Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS. 2009. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324:218-233
83. Iossifov I, Ronemus M, Levy D, Wang Z, Hakker I, et al. 2012. De novo gene disruptions in children on the autistic spectrum. Neuron 74:285-999
84. Jain RG, Andrews LG, McGowan KM, Pekala PH, Keene JD. 1997. Ectopic expression of Hel-N1, an RNAbinding protein, increases glucose transporter (GluT1) expression in 3T3-L1 adipocytes. Mol. Cell. Biol. 17:954-622
85. Jensen KB, Darnell RB. 2008. CLIP: crosslinking and immunoprecipitation of in vivo RNA targets of RNAbinding proteins. Methods Mol. Biol. 488:85-988
86. Jensen KB, Dredge BK, Stefani G, Zhong R, Buckanovich RJ, et al. 2000a. Nova-1 regulates neuron-specific alternative splicing and is essential for neuronal viability. Neuron 25:359-711
87. Jensen KB, Musunuru K, Lewis HA, Burley SK, Darnell RB. 2000b. The tetranucleotide UCAY directs the specific recognition of RNA by the Nova K-homology 3 domain. Proc. Natl. Acad. Sci. USA 97:5740-455
88. Jin P, Alisch RS, Warren ST. 2004. RNA and microRNAs in fragile X mental retardation. Nat. Cell Biol. 6:1048-533
89. Jin Y, Suzuki H, Maegawa S, Endo H, Sugano S, et al. 2003. A vertebrate RNA-binding protein Fox-1 regulates tissue-specific splicing via the pentanucleotide GCAUG. EMBO J. 22:905-122
90. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, et al. 2003. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302:2141-444
91. Kalsotra A, Xiao X, Ward AJ, Castle JC, Johnson JM, et al. 2008. A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA 105:20333-388
92. Kanadia RN, Urbinati CR, Crusselle VJ, Luo D, Lee YJ, et al. 2003. Developmental expression of mouse muscleblind genes Mbnl1, Mbnl2 and Mbnl3. Gene Expr. Patterns 3:459-622
93. Kelleher R Jr, Bear MF. 2008. The autistic neuron: troubled translation? Cell 135:401-66
94. Kim KK, Adelstein RS, Kawamoto S. 2009. Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors. J. Biol. Chem. 284:31052-611
95. Kishore S, Jaskiewicz L, Burger L, Hausser J, Khorshid M, Zavolan M. 2011. A quantitative analysis of CLIP methods for identifying binding sites of RNA-binding proteins. Nat. Methods 8:559-644
96. Kishore S, Luber S, Zavolan M. 2010. Deciphering the role of RNA-binding proteins in the posttranscriptional control of gene expression. Brief Funct. Genomics 9:391-4044
97. Konig J, Zarnack K, Luscombe NM, Ule J. 2012. Protein-RNA interactions: new genomic technologies and perspectives. Nat. Rev. Genet. 13:77-833
98. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, et al. 2010. iCLIP reveals the function of hnRNP particles in splicing at individual nucleotide resolution. Nat. Struct. Mol. Biol. 17:909-155
99. Konig J, Zarnack K, Rot G, Curk T, Kayikci M, et al. 2011. iCLIP - transcriptome-wide mapping of protein- RNA interactions with individual nucleotide resolution. J. Vis. Exp. 30:pii:26388
100. Koushika SP, Lisbin MJ, White K. 1996. Elav, a Drosophila neuron-specific protein, mediates the generation of an alternatively spliced neural protein isoform. Curr. Biol. 6:1634-411
101. Koushika SP, Soller M, White K. 2000. The neuron-enriched splicing pattern of Drosophila erect wing is dependent on the presence of ELAV protein. Mol. Cell. Biol. 20:1836-455
102. Krol J, Busskamp V, Markiewicz I, Stadler MB, Ribi S, et al. 2010. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141:618-311
103. Kuroyanagi H. 2009. Fox-1 family of RNA-binding proteins. Cell Mol. Life Sci. 66:3895-9077
104. Lee EK, Kim W, Tominaga K, Martindale JL, Yang X, et al. 2012. RNA-binding protein HuD controls insulin translation. Mol. Cell 45:826-355
105. Lee HY, Ge WP, Huang W, He Y, Wang GX, et al. 2011. Bidirectional regulation of dendritic voltage-gated potassium channels by the fragile X mental retardation protein. Neuron 72:630-422
106. Lee JA, Tang ZZ, Black DL. 2009. An inducible change in Fox-1/A2BP1 splicing modulates the alternative splicing of downstream neuronal target exons. Genes Dev. 23:2284-933
107. Lerner MR, Boyle JA, Hardin JA, Steitz JA. 1981. Two novel classes of small ribonucleoproteins detected by antibodies associated with lupus erythematosus. Science 211:400-22
108. Levine TD, Gao F, King PH, Andrews LG, Keene JD. 1993. Hel-N1: an autoimmune RNA-binding protein with specificity for 3′ uridylate-rich untranslated regions of growth factor mRNA's. Mol. Cell. Biol. 13:3494-5044
109. Lewis HA, Chen H, Edo C, Buckanovich RJ, Yang YY, et al. 1999. Crystal structures of Nova-1 and Nova-2 K-homology RNA-binding domains. Structure 7:191-2033
110. Lewis HA, Musunuru K, Jensen KB, Edo C, Chen H, et al. 2000. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome. Cell 100:323-322
111. Licatalosi DD, Darnell RB. 2006. Splicing regulation in neurologic disease. Neuron 52:93-1011
112. Licatalosi DD, Darnell RB. 2010. RNA processing and its regulation: global insights into biological networks. Nat. Rev. Genet. 11:75-877
113. Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, et al. 2008. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 456:464-699
114. Licatalosi DD, Yano M, Fak JJ, Mele A, Grabinski SE, et al. 2012. Ptbp2 represses adult-specific splicing to regulate the generation of neuronal precursors in the embryonic brain. Genes Dev. 26:1626-422
115. Lim J, Hao T, Shaw C, Patel AJ, Szabo G, et al. 2006. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 125:801-144
116. Liu N, Landreh M, Cao K, Abe M, Hendriks GJ, et al. 2012. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nature 482:519-233
117. Llorian M, Schwartz S, Clark TA, Hollander D, Tan LY, et al. 2010. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol. 17:1114-233
118. Luque FA, Furneaux HM, Ferziger R, Rosenblum MK, Wray SH, et al. 1991. Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer. Ann. Neurol. 29:241-511
119. Lynch MA. 2004. Long-term potentiation and memory. Physiol. Rev. 84:87-1366
120. Magavi SS, Macklis JD. 2008. Immunocytochemical analysis of neuronal differentiation. Methods Mol. Biol. 438:345-522
121. Makeyev EV, Zhang J, Carrasco MA, Maniatis T. 2007. The microRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Mol. Cell 27:435-488
122. Markovtsov V, Nikolic JM, Goldman JA, Turck CW, Chou MY, Black DL. 2000. Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol. Cell. Biol. 20:7463-799
123. Matlin AJ, Southby J, Gooding C, Smith CW. 2007. Repression of alpha-actinin SM exon splicing by assisted binding of PTB to the polypyrimidine tract. RNA 13:1214-233
124. McKeever MO, Darnell RB. 1992. NAP, a human cerebellar degeneration antigen, is a novel, neuron specific, adaptin family member. Soc. Neurosci. Abstr. 18:10922
125. Meins M, Schlickum S, Wilhelm C, Missbach J, Yadav S, et al. 2002. Identification and characterization of murine Brunol4, a new member of the elav/bruno family. Cytogenet. Genome Res. 97:254-600
126. Meisner NC, Filipowicz W. 2011. Properties of the regulatory RNA-binding protein HuR and its role in controlling miRNA repression. Adv. Exp. Med. Biol. 700:106-233
127. Mendell JT, Olson EN. 2012. MicroRNAs in stress signaling and human disease. Cell 148:1172-877
128. Ming GL, Wong ST, Henley J, Yuan XB, Song HJ, et al. 2002. Adaptation in the chemotactic guidance of nerve growth cones. Nature 417:411-188
129. Mortazavi A, Williams BA, McCue K, Schaeffer L, Wold B. 2008. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Methods 5:621-288
130. Muddashetty RS, Nalavadi VC, Gross C, Yao X, Xing L, et al. 2011. Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling. Mol. Cell 42:673-888
131. Musunuru K, Darnell RB. 2001. Paraneoplastic neurologic disease antigens: RNA-binding proteins and signaling proteins in neuronal degeneration. Annu. Rev. Neurosci. 24:239-622
132. Myer VE, Fan XC, Steitz JA. 1997. Identification ofHuR as a protein implicated in AUUUA-mediatedmRNA decay. EMBO J. 16:2130-399
133. Nagalakshmi U, Wang Z, Waern K, Shou C, Raha D, et al. 2008. The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320:1344-499
134. Nakamura M, Okano H, Blendy JA, Montell C. 1994. Musashi, a neural RNA-binding protein required for Drosophila adult external sensory organ development. Neuron 13:67-811
135. Narayanan U, Nalavadi V, Nakamoto M, Pallas DC, Ceman S, et al. 2007. FMRP phosphorylation reveals an immediate-early signaling pathway triggered by group I mGluR and mediated by PP2A. J. Neurosci. 27:14349-577
136. Newman LS, McKeever MO, Okano HJ, Darnell RB. 1995. R-NAP, a cerebellar degeneration antigen, is a neuron-specific vesicle coat protein. Cell 82:773-833
137. O'Carroll D, Schaefer A. 2012. General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 38:39-544
138. O'Donnell WT, Warren ST. 2002. A decade of molecular studies of fragile X syndrome. Annu. Rev. Neurosci. 25:315-388
139. Okabe M, Imai T, Kurusu M, Hiromi Y, Okano H. 2001. Translational repression determines a neuronal potential in Drosophila asymmetric cell division. Nature 411:94-988
140. Okano H, Kawahara H, Toriya M, Nakao K, Shibata S, Imai T. 2005. Function of RNA-binding protein Musashi-1 in stem cells. Exp. Cell Res. 306:349-566
141. Okano HJ, Darnell RB. 1997. A hierarchy of Hu RNA binding proteins in developing and adult neurons. J. Neurosci. 17:3024-377
142. Pan Q, Shai O, Misquitta C, Zhang W, Saltzman AL, et al. 2004. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Mol. Cell 16:929-411
143. Park TJ, Curran T. 2010. Alternative splicing disabled by Nova2. Neuron 66:811-133
144. Patel VL, Mitra S, Harris R, Buxbaum AR, Lionnet T, et al. 2012. Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. Genes Dev. 26:43-533
145. Peng SS, Chen CY, Xu N, Shyu AB. 1998. RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J. 17:3461-700
146. Perez I, Lin CH, McAfee JG, Patton JG. 1997. Mutation of PTB binding sites causes misregulation of alternative 3′ splice site selection in vivo. RNA 3:764-788
147. Polydorides AD, Okano HJ, Yang YY, Stefani G, Darnell RB. 2000. A brain-enriched polypyrimidine tractbinding protein antagonizes the ability ofNova to regulate neuron-specific alternative splicing. Proc. Natl. Acad. Sci. USA 97:6350-555
148. Poulos MG, Batra R, Charizanis K, Swanson MS. 2011. Developments in RNA splicing and disease. Cold Spring Harb. Perspect. Biol. 3(1):a0007788
149. Racca C, Gardiol A, Eom T, Ule J, Triller A, Darnell RB. 2010. The neuronal splicing factor Nova co-localizes with target RNAs in the dendrite. Front. Neural Circuits 4:55
150. Racca C, Gardiol A, Triller A. 1997. Dendritic and postsynaptic localizations of glycine receptor alpha subunit mRNAs. J. Neurosci. 17:1691-7000
151. Ratti A, Fallini C, Colombrita C, Pascale A, Laforenza U, et al. 2008. Post-transcriptional regulation of neurooncological ventral antigen 1 by the neuronal RNA-binding proteins ELAV. J. Biol. Chem. 283:7531-411
152. Reetz A, Solimena M, Matteoli M, Folli F, Takei K, De Camilli P. 1991. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-likemicrovesicles suggests their role in GABA storage and secretion. EMBO J. 10:1275-844
153. Richard S. 2010. Reaching for the stars: linking RNA binding proteins to diseases. Adv. Exp. Med. Biol. 693:142-577
154. Richter JD. 2007. CPEB: a life in translation. Trends Biochem. Sci. 32:279-855
155. Richter JD. 2010. Translational control of synaptic plasticity. Biochem. Soc. Trans. 38:1527-300
156. Robinow S, Campos A, Yao K, White K. 1988. The elav gene product of Drosophila, required in neurons, has three RNP consensus motifs. Science 242:1570-722
157. Ruggiu M, Herbst R, Kim N, Jevsek M, Fak JJ, et al. 2009. Rescuing Z+ agrin splicing in Nova null mice restores synapse formation and unmasks a physiologic defect in motor neuron firing. Proc. Natl. Acad. Sci. USA 106:3513-188
158. Sakakibara S, Imai T, Hamaguchi K, Okabe M, Aruga J, et al. 1996. Mouse-musashi-1, a neural RNA binding protein highly enriched in the mammalian CNS stem cell. Dev. Biol. 176:230-422
159. Sakakibara S, Nakamura Y, Yoshida T, Shibata S, Koike M, et al. 2002. RNA-binding proteinMusashi family: roles for CNS stem cells and a subpopulation of ependymal cells revealed by targeted disruption and antisense ablation. Proc. Natl. Acad. Sci. USA 99:15194-999
160. Sakakibara S, Okano H. 1997. Expression of neural RNA-binding proteins in the postnatal CNS: implications of their roles in neuronal and glial cell development. J. Neurosci. 17:8300-122
161. Schmidt EF, Warner-Schmidt JL, Otopalik BG, Pickett SB, Greengard P, Heintz N. 2012. Identification of the cortical neurons that mediate antidepressant responses. Cell 149:1152-633
162. Schratt GM, Tuebing F, Nigh EA, Kane CG, Sabatini ME, et al. 2006. A brain-specific microRNA regulates dendritic spine development. Nature 439:283-899
163. Schuman EM, Dynes JL, Steward O. 2006. Synaptic regulation of translation of dendritic mRNAs. J. Neurosci. 26:7143-466
164. Sharma S, Maris C, Allain FH, Black DL. 2011. U1snRNAdirectly interactswith polypyrimidine tract-binding protein during splicing repression. Mol. Cell 41:579-888
165. Shibata H, Huynh DP, Pulst SM. 2000. A novel protein with RNA-binding motifs interacts with ataxin-2. Hum. Mol. Genet. 9:1303-133
166. Siegel G, Saba R, Schratt G. 2011. MicroRNAs in neurons: manifold regulatory roles at the synapse. Curr. Opin. Genet. Dev. 21:491-977
167. Silberberg G, Ohman M. 2011. The edited transcriptome: novel high throughput approaches to detect nucleotide deamination. Curr. Opin. Genet. Dev. 21:401-66
168. Singh R, Valcarcel J, Green MR. 1995. Distinct binding specificities and functions of higher eukaryotic polypyrimidine tract-binding proteins. Science 268:1173-766
169. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-988
170. Smukler SR, Arntfield ME, Razavi R, Bikopoulos G, Karpowicz P, et al. 2011. The adult mouse and human pancreas contain rare multipotent stem cells that express insulin. Cell Stem Cell 8:281-933
171. Soller M, White K. 2003. ELAV inhibits 3′-end processing to promote neural splicing of ewg pre-mRNA. Genes Dev. 17:2526-388
172. Soller M, White K. 2005. ELAV multimerizes on conserved AU4-6 motifs important for ewg splicing regulation. Mol. Cell. Biol. 25:7580-911
173. Spellman R, Rideau A, Matlin A, Gooding C, Robinson F, et al. 2005. Regulation of alternative splicing by PTB and associated factors. Biochem. Soc. Trans. 33:457-600
174. Steward O, Schuman EM. 2001. Protein synthesis at synaptic sites on dendrites. Annu. Rev. Neurosci. 24:299-3255
175. Sugimoto Y, Konig J, Hussain S, Zupan B, Curk T, et al. 2012. Analysis of CLIP and iCLIP methods for nucleotide-resolution studies of protein-RNA interactions. Genome Biol. 13:R677
176. Sugnet CW, Srinivasan K, Clark TA, O'Brien G, Cline MS, et al. 2006. Unusual intron conservation near tissue-regulated exons found by splicing microarrays. PLoS Comput. Biol. 2:e44
177. Sutton MA, Wall NR, Aakalu GN, Schuman EM. 2004. Regulation of dendritic protein synthesis by miniature synaptic events. Science 304:1979-833
178. Szabo A, Dalmau J, Manley G, Rosenfeld M, Wong E, et al. 1991. HuD, a paraneoplastic encephalomyelitis antigen contains RNA-binding domains and is homologous to Elav and sex lethal. Cell 67:325-333
179. Tang ZZ, Zheng S, Nikolic J, Black DL. 2009. Developmental control of CaV1. 2 L-type calcium channel splicing by Fox proteins. Mol. Cell. Biol. 29:4757-655
180. Teplova M, Malinina L, Darnell JC, Song J, Lu M, et al. 2011. Protein-RNA and protein-protein recognition by dual KH1/2 domains of the neuronal splicing factor Nova-1. Structure 19:930-444
181. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, et al. 2011. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 14:452-588
182. Tsai DE, Harper DS, Keene JD. 1991. U1-snRNP-A protein selects a ten nucleotide consensus sequence from a degenerate RNA pool presented in various structural contexts. Nucleic Acids Res. 19:4931-366
183. Tuerk C, Gold L. 1990. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249:505-100
184. Ule J, Darnell RB. 2006. RNA binding proteins and the regulation of neuronal synaptic plasticity. Curr. Opin. Neurobiol. 16:102-100
185. Ule J, Jensen K, Mele A, Darnell RB. 2005a. CLIP: a method for identifying protein-RNA interaction sites in living cells. Methods 37:376-866
186. Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. 2003. CLIP identifiesNova-regulatedRNAnetworks in the brain. Science 302:1212-155
187. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, et al. 2006. An RNA map predicting Nova-dependent splicing regulation. Nature 444:580-866
188. Ule J, Ule A, Spencer J, Williams A, Hu JS, et al. 2005b. Nova regulates brain-specific splicing to shape the synapse. Nat. Genet. 37:844-522
189. Underwood JG, Boutz PL, Dougherty JD, Stoilov P, Black DL. 2005. Homologues of the Caenorhabditis elegans Fox-1 protein are neuronal splicing regulators in mammals. Mol. Cell. Biol. 25:10005-166
190. Voineagu I, Wang X, Johnston P, Lowe JK, Tian Y, et al. 2011. Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474:380-844
191. Wagnon JL, Mahaffey CL, Sun W, Yang Y, Chao HT, Frankel WN. 2011. Etiology of a genetically complex seizure disorder in Celf4 mutant mice. Genes Brain Behav. 10:765-777
192. Wang ET, Cody NA, Jog S, Biancolella M, Wang TT, et al. 2012. Transcriptome-wide regulation of premRNA splicing and mRNA localization by muscleblind proteins. Cell 150:710-244
193. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, et al. 2008. Alternative isoform regulation in human tissue transcriptomes. Nature 456:470-766
194. Wang H, Molfenter J, Zhu H, Lou H. 2010a. Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members. Nucleic Acids Res. 38:3760-700
195. Wang LW, Berry-Kravis E, Hagerman RJ. 2010b. Fragile X: leading the way for targeted treatments in autism. Neurotherapeutics 7:264-744
196. Wang Z, Kayikci M, Briese M, Zarnack K, Luscombe NM, et al. 2010c. iCLIP predicts the dual splicing effects of TIA-RNA interactions. PLoS Biol. 8:1-166
197. Weill L, Belloc E, Bava FA, Mendez R. 2012. Translational control by changes in poly(A) tail length: recycling mRNAs. Nat. Struct. Mol. Biol. 19:577-855
198. Wheeler TM, Lueck JD, Swanson MS, Dirksen RT, Thornton CA. 2007. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J. Clin. Invest. 117:3952-577
199. Wheeler TM, Sobczak K, Lueck JD, Osborne RJ, Lin X, et al. 2009. Reversal of RNA dominance by displacement of protein sequestered on triplet repeat RNA. Science 325:336-399
200. Witten JT, Ule J. 2011. Understanding splicing regulation throughRNAsplicingmaps. Trends Genet. 27:89-977
201. Wolf HK, Buslei R, Schmidt-Kastner R, Schmidt-Kastner PK, Pietsch T, et al. 1996. NeuN: a useful neuronal marker for diagnostic histopathology. J. Histochem. Cytochem. 44:1167-711
202. Xue Y, Zhou Y, Wu T, Zhu T, Ji X, et al. 2009. Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell 36:996-10066
203. Yang YY, Yin GL, Darnell RB. 1998. The neuronal RNA-binding protein Nova-2 is implicated as the autoantigen targeted in POMA patients with dementia. Proc. Natl. Acad. Sci. USA 95:13254-599
204. Yano M, Hayakawa-Yano Y, Mele A, Darnell RB. 2010. Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. Neuron 66:848-588
205. Yao KM, Samson ML, Reeves R, White K. 1993. Gene elav of Drosophila melanogaster: a prototype for neuronal-specific RNA binding protein gene family that is conserved in flies and humans. J. Neurobiol. 24:723-399
206. Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, Gage FH. 2009. An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol. 16:130-377
207. Yuan Y, Compton SA, Sobczak K, Stenberg MG, Thornton CA, et al. 2007. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 35:5474-866
208. Zang JB, Nosyreva ED, Spencer CM, Volk LJ, Musunuru K, et al. 2009. A mousemodel of the human Fragile X syndrome I304N mutation. PLoS Genet. 5:e10007588
209. Zhang C, Darnell RB. 2011. Mapping in vivo protein-RNA interactions at single-nucleotide resolution from HITS-CLIP data. Nat. Biotechnol. 29:607-144
210. Zhang C, Frias MA, Mele A, Ruggiu M, Eom T, et al. 2010. Integrative modeling defines the Nova splicingregulatory network and its combinatorial controls. Science 329:439-433
211. Zhang C, Zhang Z, Castle J, Sun S, Johnson J, et al. 2008. Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. Genes Dev. 22:2550-633
212. Zhang X, Poo MM. 2002. Localized synaptic potentiation by BDNF requires local protein synthesis in the developing axon. Neuron 36:675-888
213. Zhu H, Hasman RA, Barron VA, Luo G, Lou H. 2006. A nuclear function of Hu proteins as neuron-specific alternative RNA processing regulators. Mol. Biol. Cell 17:5105-144
214. Zhu H, Hinman MN, Hasman RA, Mehta P, Lou H. 2008. Regulation of neuron-specific alternative splicing of neurofibromatosis type 1 pre-mRNA. Mol. Cell. Biol. 28:1240-511